How Klein was paid
$23.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Matthew B. KleinChief Executive Officer | $958,500 | $16,593,800 | $4,399,760 | $1,294,000 | $20,266 | $23,266,326 |
| Pierre GravierChief Financial Officer | $579,167 | $1,047,150 | $1,414,209 | $488,600 | $21,660 | $3,550,786 |
| Eric PauwelsChief Business Officer | $613,150 | $1,023,880 | $1,382,782 | $517,800 | $25,356 | $3,562,968 |
| Lee GoldenExecutive Vice President and Chief Medical Officer | $574,667 | $930,800 | $1,257,074 | $482,800 | $23,838 | $3,269,179 |
| Neil AlmsteadChief Technical Operations Officer | $582,500 | $884,260 | $1,194,221 | $467,400 | $30,674 | $3,159,055 |
What changed and why
- $23.3MChief Executive Officer total compensation increased to $23,266,326 in 2025 due to large equity grants.
- Dr. Klein received a performance stock unit award in December 2025 tied to relative TSR.
- 95.9%Variable elements comprised 95.9% of the Chief Executive Officer's primary compensation in 2025.
- 96.8%Stockholders approved the 2025 say-on-pay proposal with approximately 96.8% support.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.